80052967 - Retina Festival 2020 - EM

Thursday, October 1, 2020, 7:30 AM - Thursday, September 30, 2021, 5:00 PM EST


Retina Festival 2020 is an “all-star” line-up of more than 50 faculty members from around the world participating in a Continuing Medical Education event from the Wilmer Eye Institute of the Johns Hopkins School of Medicine. The program provides the latest updates from clinical trials and other evidence in the peer-reviewed medical literature that are relevant to the prevention and management of retinal diseases around the world. Topics include the latest, clinically relevant outcomes from clinical trials on age-related macular degeneration, vitreomacular interface abnormalities, hereditary retinal degenerations, diabetic retinopathy, retinal vein occlusions, and the latest in retinal surgery, including live retina surgery demonstrations. In addition to presentations from world experts, four panels of experts throughout the course will highlight discussions on applying clinical trial results to day-to-day clinical practice.

WHO SHOULD ATTEND
This activity is intended for comprehensive ophthalmologists, retina specialists, both expert and in training, as well as vision scientists who want an update on the latest clinically relevant topics in retina.

FEES

Registration Fee..................................................$35.00

COURSE FORMAT – METHOD OF PARTICIPATION
This enduring material is expected to take approximately 7.75 hours to complete. Once the activity is completed, you must pass the post-test and complete the online evaluation with attestation to receive CME credit.

Once you have completed registration, please click on the TEST tab to launch the webpage with the content.

HARDWARE/SOFTWARE REQUIREMENTS
Internet connection.

POST-TEST
A post-test will be conducted at the conclusion of the activity. A grade of at least 70% within three attempts is needed to receive CME credit.

HOW TO OBTAIN CREDIT
Post activity, an online evaluation form will be available to attendees to evaluate the activity and identify future educational needs. Upon completion of the evaluation, the learner must attest to the number of hours in attendance. A certificate of attendance will be available immediately for download or print. The last day to evaluate the material and attest to your credits is July 30, 2021.

1. Recognize the role of anti-angiogenic treatments for eyes with choroidal neovascularization from age-related macular degeneration or diabetic retinopathy, including proliferative diabetic retinopathy and diabetic macular edema.
2. Evaluate recent clinical studies evaluating treatments for hereditary retinal degenerations.
3. Discuss the role of imaging in the management of vitreomacular interface abnormalities.
4. Review the current and emerging therapeutic approaches for surgical retinal diseases.
5. Summarize the evidence of surgical and medical treatments for intraocular tumors.
6. Determine which patients are appropriate for biologic treatments of posterior uveitis.

ACCREDITATION STATEMENT 
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this internet live activity for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER CREDITS
The Johns Hopkins University has approved this activity for 7.75 contact hours for non-physicians.

POLICY ON PRESENTER AND PROVIDER DISCLOSURE
It is the policy of the Johns Hopkins School of Medicine that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins School of Medicine OCME has established policies that will identify and resolve conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.

 

No faculty are available for this activity at this time.